Solésence appoints Marc James as independent director to board and three committees

SOLESENCE, INC.

Marc James appointed as Class II Director effective April 24, 2026, term expires at 2026 Annual Meeting.
James will serve on Audit and Finance, Compensation, and Nominating and Corporate Governance Committees.
James brings capital markets expertise from senior managing director roles in global financial markets.
CEO Kevin Cureton cites James's strategic insight and capital markets expertise as valuable for growth strategy.
Board Chair Janet Whitmore notes the appointment expands board expertise for disciplined execution and growth.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Marc James

Class II Director

SLSN · SOLESENCE, INC.

Effective: 2026-04-24
Filed: April 29, 2026, 7:59 PM ET

Effective April 24, 2026, the Board of Directors of the Company (the "Board") appointed Marc James to serve as a Class II Director of the Board for the remainder of the term of Class II Directors of the Board, expiring at the 2026 Annual Meeting of Shareholders of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Marc James was appointed as Class II Director at SOLESENCE, INC..

Action: appointed
Role: Class II Director

Exact text from the filing

Effective April 24, 2026, the Board of Directors of the Company (the "Board") appointed Marc James to serve as a Class II Director of the Board for the remainder of the term of Class II Directors of the Board, expiring at the 2026 Annual Meeting of Shareholders of the Company.

View on SEC.gov

SOLESENCE, INC. filing history →

Source: SEC EDGAR

accession 0001171843-26-002802

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.